Skip to content
This GLP
Head to head

Trimi Health vs Harper Meds

An annual plan against an all-inclusive four-week fill.

By Dana SullivanEvidence reviewer

Trimi Health

Editorial

$99/mo

Trimi Health advertises $99 a month for compounded semaglutide and $125 for compounded tirzepatide, and bills both as an annual plan: $1,188 and $1,500, charged up front or split through a buy-now-pay-later provider. The rate is stated as flat across doses.

Pick it for: Readers who want the lowest figure and will commit a year

Harper Meds

Editorial

$161/mo

Harper Meds prices compounded semaglutide at a flat $149 and compounded tirzepatide at a flat $196, with the consultation, the prescription, four weeks of medication and free shipping inside the charge. Both rates are stated as flat at every dose. Four weeks is not a calendar month, so thirteen fills land in a year and the figures ranked here are $161 and $212.

Pick it for: Readers who want inclusions stated and no annual commitment

Our verdict

Trimi Health's figure assumes a year paid in advance. Harper Meds bills every four weeks and describes the fill as all-inclusive. Neither is a plain calendar month at a plain monthly rate.

What actually separates them

Trimi Health and Harper Meds state different things about published price. Everything else they publish, they publish the same way.

Harper Meds costs $62 more than Trimi Health — 63% more for the same molecule. Whether that buys anything is what the rest of this page is for.

Over twelve months that is about $1,188 at Trimi Health against $1,932 at Harper Meds — a difference of $744.

 Trimi HealthHarper Meds
Published price$99/mo$161/mo

Before you choose either

Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.

Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.

All head-to-head comparisons · The buyer’s guides